(Q48096115)

8 February 2018

title

TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. (English)

1 reference

8 February 2018

0 references

Sandrine Rorive

1

1 reference

8 February 2018

Xavier Moles Lopez

2

1 reference

8 February 2018

Calliope Maris

3

1 reference

8 February 2018

Anne-Laure Trepant

4

1 reference

8 February 2018

Sébastien Sauvage

5

1 reference

8 February 2018

Niloufar Sadeghi

6

1 reference

8 February 2018

Isabelle Roland

7

1 reference

8 February 2018

Christine Decaestecker

8

1 reference

8 February 2018

Isabelle Salmon

9

1 reference

8 February 2018

publication date

6 August 2010

1 reference

8 February 2018

published in

Modern Pathology

1 reference

8 February 2018

volume

23

1 reference

8 February 2018

issue

10

1 reference

8 February 2018

page(s)

1418-1428

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.136

exact match

0 references

cites work

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Complex roles of tissue inhibitors of metalloproteinases in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

The TIMPs tango with MMPs and more in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Tissue inhibitor of metalloproteinases-4. The road less traveled.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Novel functions of TIMPs in cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Trafficking and function of the tetraspanin CD63.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Classification and grading of low-grade astrocytic tumors in children

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Protein kinase activity is associated with CD63 in melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.136

7 January 2021

10.1038/MODPATHOL.2010.136

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

20693981

1 reference

8 February 2018